content

Gilead Sciences appoints John McHutchison, MD, Appointed Chief Scientific Officer and Andrew Cheng, MD, PhD, Appointed Chief Medical Officer

Gilead Sciences, Inc. announced that Norbert Bischofberger, PhD, has decided to step down from his role as Executive Vice President, Research and Development and...

Novartis changes its executive committees to align with its strategic goals

Novartis announced changes to its senior leadership team to support the implementation of its strategic priorities. Bertrand Bodson, Chief Digital Officer, Steffen Lang, Global...

Largest Real-World Data Analysis Reveals Findings Of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants

Bristol-Myers Squibb Company and Pfizer Inc. will present findings from a real-world data (RWD) analysis titled, Comparison of Effectiveness, Safety, and the Net Clinical...

Recipharm completes Blow-fill-seal expansion at Kaysersberg facility

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at its...

Nanologicaand Sterling partnership furthers new business venture

Nanologica AB (publ) has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production...

Alexion Announces Positive Top-Line Results Showing Successful Phase 3 Clinical Study Of ALXN1210 In Complement Inhibitor Treatment-Naรฏve Patients With Paroxysmal Nocturnal Hemoglobinuria

Alexion Pharmaceuticals, Inc. announced that the pivotal Phase 3 study of ALXN1210, the Companyโ€™s investigational long-acting C5 complement inhibitor, demonstrated non-inferiority to Solirisยฎ (eculizumab)...

Latest technology for cell-based assays now also available for our entry-level product line

Cell-based assays have become an important application in the life science sector, from basic to top-level research. They are widely used in biotech companies...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read